Oenon Holdings, Inc. engages in development of alcoholic beverages, enzymes, pharmaceuticals, real estate, and other businesses based on biotechnologies derived from fermentation technologies in Japan. The company offers alcoholic beverages, including shochu, chu-hi (RTD), sake compounds, plum wine, processed liquor, wine, spirits, imported wine, brewing, industrial alcohol, and seasonings. It also manufactures and sells enzymes comprising of lactase, glucose isomerase, isoamylase, cellulase, inulinase, and protease for food and industrial use, as well as offers dispase, a cell dispersion enzyme. In addition, the company provides active pharmaceutical ingredients; contract manufacturing services; and engaged in diagnostic medicines business. Further, it sells and leases real estate properties, as well as involved in transportation and cargo handling, and other businesses. Oenon Holdings, Inc. was incorporated in 1920 and is headquartered in Tokyo, Japan.
Metrics to compare | 2533 | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship Relationship2533PeersSector | |
---|---|---|---|---|
P/E Ratio | 10.3x | 24.6x | 11.6x | |
PEG Ratio | −1.12 | −0.80 | 0.03 | |
Price/Book | 1.2x | 1.9x | 1.5x | |
Price / LTM Sales | 0.3x | 1.5x | 0.9x | |
Upside (Analyst Target) | - | 15.8% | 17.6% | |
Fair Value Upside | Unlock | 20.7% | 11.1% | Unlock |